<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Latent autoimmune diabetes in adults (LADA) is a frequently encountered condition in medical practice. It should be suspected in patients where the type of the diabetes mellitus is not certain. LADA consists of features from both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), being a condition which is often unnoticed. Considered as type 1.5 diabetes mellitus, the lack of insulin requirement at disease onset makes it initially to be included in T2DM in terms of therapeutic management. The improvement of the screening methods allows the detection of LADA at an early stage, therefore medical intervention should be effective in preserving beta-cell function and to delay the progression of the disease.</p>
</abstract>

Latent autoimmune diabetes in adults (LADA) is a frequently encountered condition in medical practice. It should be suspected in patients where the type of the diabetes mellitus is not certain. LADA consists of features from both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), being a condition which is often unnoticed. Considered as type 1.5 diabetes mellitus, the lack of insulin requirement at disease onset makes it initially to be included in T2DM in terms of therapeutic management. The improvement of the screening methods allows the detection of LADA at an early stage, therefore medical intervention should be effective in preserving beta-cell function and to delay the progression of the disease.

Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach

“George Emil Palade” University of Medicine, Pharmacy, Science and Technology of Târgu-Mureș

Acta Medica Transilvanica

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach"}

Latent autoimmune diabetes in adults (LADA) is a frequently encountered condition in medical practice. It should be suspected in patients where the type of the...

Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach

Publié en ligne: 03 nov. 2021

Pages: 55 - 58

Reçu: 04 août 2021

Accepté: 02 sept. 2021

DOI: https://doi.org/10.2478/amtsb-2021-0052

Mots clés
diabetes mellitus, LADA, glutamic acid decarboxylase, c-peptide

© 2021 Lucia Mihaela Custură et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach

Publié en ligne: 03 nov. 2021

Pages: 55 - 58

Reçu: 04 août 2021

Accepté: 02 sept. 2021

DOI: https://doi.org/10.2478/amtsb-2021-0052

Mots clésdiabetes mellitus, LADA, glutamic acid decarboxylase, c-peptide

© 2021 Lucia Mihaela Custură et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Mots clés
diabetes mellitus, LADA, glutamic acid decarboxylase, c-peptide